|
Yararlanılan Kaynaklar
▪ Little MA, O’Riordan A,
Lucey B, Farrell M, Lee M, Conlon PJ, Walshe JJ: A prospective study
of complications associated with cuffed, tunnelled haemodialysis
catheters.
Nephrol Dial Transplant 16: 2194–2200, 2001
▪
Beathard GA: Management of bacteremia associated with tunneled-cuffed
hemodialysis catheters. J Am Soc Nephrol 10: 1045–1049, 1999
▪ Raad I. Intravascular-catheter-related
infections. Lancet 1998;351: 893–898
▪ Krishnasami Z, Carlton D,
Bimbo L et al. Management of hemodialysis catheter related
bacteremia with an adjunctive antibiotic lock solution. Kidney Int
2002; 61:1136–1142
▪ Renaat A. Peleman, Dorl
Vogelaars and Gerda Verschraegen,Changing patterns of antibiotic
resistance-update on antibiotic management of the infected vascular
access , Nephrol Dial Transplant 15: 1281–1284, 2000
▪ Zipporah Krishnasami,
Donna Carlton, Lisa Bimbo, Maria E. Taylor, Daniel F. Balkovetz,
Jill Barker, and Michael Allon, Management of hemodialysis catheter
related bacteremia with an adjunctive antibiotic lock solution ,
Kidney International, Vol. 61 (2002), pp. 1136-1142
▪ Science, 1999 May
21;284(5418):1318-22 .
▪ Crit Care Med. 1992
May;20(5):665-73.
Passerini. L, Lam K, Costerton JW, King EG
▪ Rodney M. Donlan
Centers for Disease Control and Prevention Atlanta, Georgia, USA
Emerging Infectious Diseases Vol. 7, No. 2, March–April 2001
▪ Jeffrey S. Berns, MD, and
Jerome I. Tokars, MD, Am J Kidney Dis 40:886-898. © 2002 by the
National Kidney Foundation, Inc.
▪ Karaaslan H, Peyronnet P,
Benevent D, Lagarde C, Rince M, Leroux-Robert C: Risk of heparin
lock-related bleeding when using indwelling venous catheter in
haemodialysis.
Nephrol Dial Transplant 16: 2072–2074, 2001
▪ Superior antimicrobial
activity of trisodium citrate over heparin for catheter locking
M.C. Weijmer, Y.J. Debets-Ossenkopp, F.J. van de Vondervoort and
P.M. ter Wee
Nephrol Dial Transplant (2002) 17: 2189–2195
▪ Hendrickx L, Kuypers D,
Evenepoel P, Maes B, Messiaen T, Vanrenterghem Y. Int J Artif Organs
2001 Apr;24(4):208-11
▪ Dogra GK, Herson H,
Hutchison B, Irish AB, Heath CH, Golledge C, Luxton G, Moody H. J Am
Soc Nephrol 2002 Aug;13(8):2133-9
▪ Michiel G. H. Betjes and
Madelon van Agteren, Nephrol Dial Transplant (2004) 19: 1546–1551
DOI: 10.1093/ndt/gfh014, Advance Access publication 19 February 2004
Original Article
▪ Michael Allon, Dialysis
Catheter–Related Bacteremia • Clinical Infectious Diseases. 2003:36
(15 June)
▪ M.C. Weijmer, Y.J. Debets-Ossenkopp,
F.J. van de Vondervoort and P.M. ter Wee
Nephrol Dial Transplant (2002) 17: 2189–2195
▪ Marcel C. Weijmer,
Marinus A. van den Dorpel, Peter J.G. Van de Ven, Pieter M. ter Wee,
Jos A.C.A. van Geelen, Johannes O. Groeneveld,§ Brigitte C. van
Jaarsveld, Marjon G. Koopmans, Caatje Y. le Poole, Anita M.
Schrander-Van der Meer, Carl E.H. Siegert, Koen J.F. Stas; for the
CITRATE Study Group
▪ Stephen R. Ash, Rita A.
Mankus, James M. Sutton, Ruth E. Criswell, Carol C. Crull, Katherine
A. Velasquez, Brian D. Smeltzer, Todd S. Ing ASAIO J 46:222, 2000,
Hemodialysis International 4:22-31, 2000
▪ KJF Stas, J VanWalleghem,
B de Moor, H Keuleers, Nephrol Dial Transplant (2002) 16: 1521
▪ B Bayès, J Bonal, R.
Romero, Nephrol Dial Transplant (2001) 14: 2532
▪ M.C. Weijmer, Y.J. Debets-Ossenkopp,
F.J. van de Vondervoort and P.M. ter Wee
Nephrol Dial Transplant (2002) 17: 2189–2195
▪ Bunker JP, Bendixen HH,
Murphy AJ. Hemodynamic effects of intravenously administered sodium
citrate. N Engl J Med (1962) 266:372-377.
▪ Concentrated Sodium
Citrate (23%) for Catheter Lock, Stephen R. Ash, Rita A. Mankus,
James M. Sutton, Ruth E. Criswell, Carol C. Crull, Katherine A.
Velasquez, Brian D. Smeltzer, Todd S. Ing,. Hemodial Int (2000);4:
22-31
▪ Randomized, Clinical
Trial Comparison of Trisodium Citrate 30% and Heparin as Catheter-Locking
Solution in Hemodialysis Patients, Marcel C. Weijmer, Marinus A. van
den Dorpel, Peter J.G. Van de Ven, Pieter M. ter Wee, Jos A.C.A. van
Geelen, Johannes O. Groeneveld, Brigitte C. van Jaarsveld, Marjon G.
Koopmans, Caatje Y. le Poole, Anita M. Schrander-Van der Meer, Carl
E.H. Siegert, Koen J.F. Stas; for the CITRATE Study Group, J Am Soc
Nephrol. (2005) Sep;16(9):2769-77
▪ Stas KJ, Vanwalleghem J,
Moor BD, Keuleers H: Trisodium citrate 30% vs heparin 5% as catheter
lock in the interdialytic period in twin- or double-lumen dialysis
catheters for intermittent haemodialysis. Nephrol Dial Transplant
(2001) 16: 1521–1522, 26.
▪ Bayés B, Bonal J, Romero
R: Sodium citrate for filling haemodialysis catheters. Nephrol Dial
Transplant (1999) 14: 2532 – 2533.
▪ C.J. Doorenbos et al,
poster presentation ASN 2005.
▪ Mohsen Agharazii,
Isabelle Plamondon, Marcel Lebel, Pierre Douville and Simon
Desmeules, Estimation of heparin leak into the systemic
circulationafter central venous catheter heparin lock, Nephrol Dial
Transplant (2005) 20: 1238–1240 doi:10.1093/ndt/gfh841
Biyofilm Nedir?
Neden Sitrat
▪ Heparin
▪ Düşük Konsantrasyonlu Sitrat
▪ Yüksek Konsantrasyonlu Sitrat
Yan Etkiler
Literatürler
Yararlanılan Kaynaklar |
